177 related articles for article (PubMed ID: 37273150)
1. Monocyte-to-lymphocyte ratio as predictor of cancer therapy-related cardiotoxicity in patients with breast cancer: a pilot cohort study.
Pivatto Júnior F; Santos ÂBS; Englert EF; Mazzutti G; Costa GOM; Saffi MAL; Liedke PER; Fritsch VH; Biolo A
Breast Cancer Res Treat; 2023 Aug; 200(3):355-362. PubMed ID: 37273150
[TBL] [Abstract][Full Text] [Related]
2. The prognostic and predictive role of the neutrophil-to-lymphocyte ratio and the monocyte-to-lymphocyte ratio in early breast cancer, especially in the HER2+ subtype.
Tiainen S; Rilla K; Hämäläinen K; Oikari S; Auvinen P
Breast Cancer Res Treat; 2021 Jan; 185(1):63-72. PubMed ID: 32948994
[TBL] [Abstract][Full Text] [Related]
3. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer.
Cong R; Kong F; Ma J; Li Q; Wu Q; Ma X
BMC Cancer; 2020 May; 20(1):464. PubMed ID: 32448185
[TBL] [Abstract][Full Text] [Related]
4. Prognostic utility of the combination of monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NSTEMI after primary percutaneous coronary intervention: a retrospective cohort study.
Fan Z; Li Y; Ji H; Jian X
BMJ Open; 2018 Oct; 8(10):e023459. PubMed ID: 30341133
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment serum neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios: Two tumor-related systemic inflammatory markers in patients with thymic epithelial tumors.
Wang L; Ruan M; Yan H; Lei B; Sun X; Chang C; Liu L; Xie W
Cytokine; 2020 Sep; 133():155149. PubMed ID: 32512341
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and Prognostic Value of Myocardial Work Indices for Identification of Cancer Therapy-Related Cardiotoxicity.
Calvillo-Argüelles O; Thampinathan B; Somerset E; Shalmon T; Amir E; Steve Fan CP; Moon S; Abdel-Qadir H; Thevakumaran Y; Day J; Woo A; Wintersperger BJ; Marwick TH; Thavendiranathan P
JACC Cardiovasc Imaging; 2022 Aug; 15(8):1361-1376. PubMed ID: 35926895
[TBL] [Abstract][Full Text] [Related]
7. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
[TBL] [Abstract][Full Text] [Related]
8. Monocyte-to-lymphocyte ratio as a prognostic factor in peripheral whole blood samples of colorectal cancer patients.
Jakubowska K; Koda M; Grudzińska M; Kańczuga-Koda L; Famulski W
World J Gastroenterol; 2020 Aug; 26(31):4639-4655. PubMed ID: 32884222
[TBL] [Abstract][Full Text] [Related]
9. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?
Solmaz Medeni S; Acar C; Olgun A; Acar A; Seyhanlı A; Taskıran E; Sevindik OG; Alacacıoglu I; Piskin O; Ozcan MA; Demirkan F; Undar B; Ozsan GH
Clin Transplant; 2018 Sep; 32(9):e13359. PubMed ID: 30053318
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the combination of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio on mortality in patients on maintenance hemodialysis.
Liao J; Wei D; Sun C; Yang Y; Wei Y; Liu X
BMC Nephrol; 2022 Dec; 23(1):393. PubMed ID: 36482367
[TBL] [Abstract][Full Text] [Related]
11. Assessment efficacy of neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in preeclampsia.
Wang J; Zhu QW; Cheng XY; Liu JY; Zhang LL; Tao YM; Cui YB; Wei Y
J Reprod Immunol; 2019 Apr; 132():29-34. PubMed ID: 30861482
[TBL] [Abstract][Full Text] [Related]
12. Preoperative neutrophil-to-lymphocyte, platelet-to-lymphocyte and monocyte-to-lymphocyte ratio as a prognostic factor in non-endometrioid endometrial cancer.
Song H; Jeong MJ; Cha J; Lee JS; Yoo JG; Song MJ; Kim JH; Lee SJ; Lee HN; Yoon JH; Park DC; Kim SI
Int J Med Sci; 2021; 18(16):3712-3717. PubMed ID: 34790044
[No Abstract] [Full Text] [Related]
13. Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma.
Shi L; Qin X; Wang H; Xia Y; Li Y; Chen X; Shang L; Tai YT; Feng X; Acharya P; Acharya C; Xu Y; Deng S; Hao M; Zou D; Zhao Y; Ru K; Qiu L; An G
Oncotarget; 2017 Mar; 8(12):18792-18801. PubMed ID: 27852046
[TBL] [Abstract][Full Text] [Related]
14. Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography.
Houbois CP; Nolan M; Somerset E; Shalmon T; Esmaeilzadeh M; Lamacie MM; Amir E; Brezden-Masley C; Koch CA; Thevakumaran Y; Yan AT; Marwick TH; Wintersperger BJ; Thavendiranathan P
JACC Cardiovasc Imaging; 2021 May; 14(5):962-974. PubMed ID: 33248962
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction.
Narayan HK; French B; Khan AM; Plappert T; Hyman D; Bajulaiye A; Domchek S; DeMichele A; Clark A; Matro J; Bradbury A; Fox K; Carver JR; Ky B
JACC Cardiovasc Imaging; 2016 Oct; 9(10):1131-1141. PubMed ID: 27085442
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in women with hyperglycemia.
Wang J; Zhu QW; Cheng XY; Sha CX; Cui YB
Postgrad Med; 2020 Nov; 132(8):702-708. PubMed ID: 32425090
[No Abstract] [Full Text] [Related]
17. Cancer Therapeutics-Related Cardiac Dysfunction among Patients with Active Breast Cancer: A Cardio-Oncology Registry.
Laufer-Perl M; Mor L; Milwidsky A; Derakhshesh M; Amrami N; Moshkovits Y; Arnold J; Topilsky Y; Arbel Y; Rozenbaum Z
Isr Med Assoc J; 2020 Sep; 22(9):564-568. PubMed ID: 33236555
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of the neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-neutrophil ratio, and neutrophil-to-monocyte ratio in lupus nephritis.
Liu P; Li P; Peng Z; Xiang Y; Xia C; Wu J; Yang B; He Z
Lupus; 2020 Aug; 29(9):1031-1039. PubMed ID: 32501169
[TBL] [Abstract][Full Text] [Related]
19. A High Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Advanced Gallbladder Cancer Receiving Chemotherapy.
Choi YH; Lee JW; Lee SH; Choi JH; Kang J; Lee BS; Paik WH; Ryu JK; Kim YT
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1045-1051. PubMed ID: 30842131
[TBL] [Abstract][Full Text] [Related]
20. Prognostic utility of the combination of pretreatment monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NMIBC after transurethral resection.
Wang Q; Huang T; Ji J; Wang H; Guo C; Sun X; Zheng K; Dong Z; Cao Y
Biomark Med; 2019 Dec; 13(18):1543-1555. PubMed ID: 31621380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
